Related Experiment Videos
[Thrombolysis in myocardial infarction-outcome optimization methods]
Insights
Successful thrombolytic therapy for acute myocardial infarction (AMI) using streptokinase (STK) depends on Killip class, time to treatment, and time of day. These factors are more predictive than gender or age for STK treatment outcomes.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Early reperfusion in acute myocardial infarction (AMI) is crucial for limiting myocardial damage and improving patient prognosis.
- Several factors, including gender, smoking, age, and infarct location, may influence AMI outcomes and thrombolytic therapy effectiveness.
- Streptokinase (STK) is a common thrombolytic agent used in AMI treatment.
Purpose of the Study:
- To identify key factors predicting the success of thrombolytic therapy with streptokinase (STK) in patients with acute myocardial infarction (AMI).
- To analyze the relationship between patient characteristics, treatment timing, and thrombolytic therapy outcomes.
Main Methods:
- Retrospective analysis of 156 patients (122 male, 34 female) treated with STK for AMI.
- Patients were categorized into three groups based on thrombolytic success: successful, probably successful, and failed, using clinical and TIMI flow criteria.
- Multiple regression analysis was employed to identify independent predictive factors for successful thrombolysis.
Main Results:
- Killip class (p = 0.0005), time from pain onset to thrombolysis initiation (p = 0.02), and time of day of thrombolysis initiation (p = 0.037) were identified as significant independent predictors of successful STK therapy.
- Factors such as gender, age, and smoking status did not demonstrate similar predictive power for thrombolytic success.
- Successful reperfusion was achieved in 88 patients, with 20 probably successful and 48 experiencing failed thrombolysis.
Conclusions:
- Killip class, treatment delay, and time of day are critical determinants for successful streptokinase thrombolysis in acute myocardial infarction.
- These findings suggest potential for optimizing STK therapy through tailored dosing or timing strategies.
- Consideration of primary percutaneous coronary intervention (PTCA) may be warranted, particularly in the early morning hours, if thrombolysis is likely to fail.
Abstract:
Early reperfusion in acute myocardial infarction (AMI) has been shown to reduce the extent of myocardial necrosis and to improve short and long term prognosis. Gender, smoking, age and site of infarct location may be regarded as prognostic factors for the outcome of AMI and of thrombolytic therapy with streptokinase (STK). The aim of this study was to identify factors, which are related to the results of thrombolytic therapy by STK in AMI. 156 patients (122 males and 34 females) treated with STK were retrospectively analyzed: they were subdivided into 3 groups according to the presumed success of thrombolytic therapy based on the accepted clinical and angiographic TIMI flow criteria. Group 1 = successful (88 patients), group 2 = probably successful (20 patients) and group 3 = failed thrombolysis (48 patients). Multiple regression analysis showed that Killip class (p = 0.0005), time from pain onset to thrombolysis initiation (p = 0.02) and the time of the day in which thrombolysis began (p = 0.037) are independent major predictive factors for successful thrombolytic therapy by STK in AMI. Gender, age, smoking and some risk factors are not of similar predictive power. These results may guide us in the optimization of thrombolytic therapy by STK in AMI, different dose regimens for different times of day and probably preference for primary PTCA in the early morning hours.